GlaxoSmithKline PLC (UK) Price on July 13, 2023
| GSK Stock | 1,335 5.50 0.41% |
Below is the normalized historical share price chart for GlaxoSmithKline PLC extending back to June 19, 1989. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GlaxoSmithKline PLC stands at 1,335, as last reported on the 1st of December, with the highest price reaching 1,340 and the lowest price hitting 1,324 during the day.
If you're considering investing in GlaxoSmithKline Stock, it is important to understand the factors that can impact its price. GlaxoSmithKline PLC holds Efficiency (Sharpe) Ratio of -0.24, which attests that the entity had a -0.24% return per unit of standard deviation over the last 3 months. GlaxoSmithKline PLC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GlaxoSmithKline PLC's risk adjusted performance of (0.19), and Market Risk Adjusted Performance of (1.14) to validate the risk estimate we provide.
At present, GlaxoSmithKline PLC's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 1.5 B, whereas Liabilities And Stockholders Equity is forecasted to decline to about 32.8 B. . GlaxoSmithKline Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.6 K | 50 Day MA 1.4 K | Beta 0.33 |
GlaxoSmithKline |
Sharpe Ratio = -0.245
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GSK |
Estimated Market Risk
| 1.21 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GlaxoSmithKline PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GlaxoSmithKline PLC by adding GlaxoSmithKline PLC to a well-diversified portfolio.
Price Book 3.8888 | Enterprise Value Ebitda 10.039 | Price Sales 1.747 | Shares Float 3.9 B | Dividend Share 0.61 |
GlaxoSmithKline PLC Main Headline on 13th of July 2023
GlaxoSmithKline PLC dividend paid on 13th of July 2023 |
GlaxoSmithKline PLC Valuation on July 13, 2023
It is possible to determine the worth of GlaxoSmithKline PLC on a given historical date. On July 13, 2023 GlaxoSmithKline was worth 1251.89 at the beginning of the trading date compared to the closed value of 1253.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline PLC stock. Still, in general, we apply an absolute valuation method to find GlaxoSmithKline PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlaxoSmithKline PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GlaxoSmithKline PLC's related companies.
| Open | High | Low | Close | Volume | |
| 1,245 | 1,257 | 1,237 | 1,256 | 11,626,180 | |
07/13/2023 | 1,252 | 1,265 | 1,251 | 1,254 | 8,344,519 |
| 1,241 | 1,259 | 1,238 | 1,245 | 4,731,727 |
| Backtest GlaxoSmithKline PLC | | | GlaxoSmithKline PLC History | | | GlaxoSmithKline PLC Valuation | Previous | Next |
GlaxoSmithKline PLC Trading Date Momentum on July 13, 2023
| On July 14 2023 GlaxoSmithKline PLC was traded for 1,245 at the closing time. The highest price during the trading period was 1,259 and the lowest recorded bid was listed for 1,238 . The volume for the day was 4.7 M. This history from July 14, 2023 contributed to the next trading day price decline. The overall trading delta to the next closing price was 0.74% . The overall trading delta to the current price is 4.42% . |
GlaxoSmithKline PLC Fundamentals Correlations and Trends
By evaluating GlaxoSmithKline PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GlaxoSmithKline PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GlaxoSmithKline financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GlaxoSmithKline PLC Stock history
GlaxoSmithKline PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GlaxoSmithKline is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GlaxoSmithKline PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GlaxoSmithKline PLC stock prices may prove useful in developing a viable investing in GlaxoSmithKline PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.1 B | 4.7 B | |
| Net Income Applicable To Common Shares | 17.2 B | 18.1 B |
GlaxoSmithKline PLC Stock Technical Analysis
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
GlaxoSmithKline PLC Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
GlaxoSmithKline PLC cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GlaxoSmithKline PLC December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC entry and exit signals to maximize returns
GlaxoSmithKline PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GlaxoSmithKline PLC's price direction in advance. Along with the technical and fundamental analysis of GlaxoSmithKline Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GlaxoSmithKline to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (1.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |